Dr. Reddy's launches generic Suboxone in the U.S. Market

Company |  News | 0 Comment | 15 Jun, 2018

Dr. Reddy’s Laboratories Ltd. has received final approval from the U.S. Food and Drug Administration (USFDA) and is launching Buprenorphine and Naloxone Sublingual Film, 2 mg/0.5 mg, ...Read more

Strategic acquisition of GlobalSpace in Miljon Medi APP

Company |  News | 0 Comment | 15 Jun, 2018

GlobalSpace Technologies Limited a fast-growing new-age technology company today announced the acquisition of 70.80% stake in Miljon Medi APP for an undisclosed sum.   Miljon Medi AP...Read more

Lupin brings generic antibiotic inhalation solution in US market

Company |  News | 0 Comment | 14 Jun, 2018

Drug firm Lupin today said it has launched its antibiotic Tobramycin inhalation solution in the US market.   The company has launched the product as it has received an approval from ...Read more

J&J announces Health for Humanity report

Company |  News | 0 Comment | 11 Jun, 2018

Johnson & Johnson has released its 2017 Health for Humanity Report, demonstrating its approach and the considerable progress it has made toward an ambitious social, envir...Read more

MedGenome's OncoPept wins Best Overall Genomic Solution Award

Company |  News | 0 Comment | 11 Jun, 2018

MedGenome's OncoPept platform of advanced genomics-based solutions designed to accelerate cancer immune-oncology research, was named the winner of the 2018 MedTech Breakthrough Awards for '...Read more

Natco Pharma introduces generic Posaconazole injection in India

Company |  News | 0 Comment | 11 Jun, 2018

Natco Pharma has launched a generic version of Posaconazole Injection, 300 mg/16.7ml, under its brand POSANAT.   This is the first time an injection version of this drug is available...Read more

Alembic Pharma gets USFDA permission for anti-depression drug

Company |  News | 0 Comment | 11 Jun, 2018

Alembic Pharmaceuticals has received the US health regulator's nod for Bupropion Hydrochloride tablets, used for treatment of major depressive disorder.   "The company has received a...Read more

USFDA approves Aurobindo’s heartburn drug

Company |  News | 0 Comment | 08 Jun, 2018

Aurobindo Pharma has received final approval from the US health regulator to manufacture Omeprazole delayed-release tablets OTC, 20mg, used in the treatment of frequent heartburn. The appro...Read more

FGI confers Sun Pharma with CSR award

Company |  News | 0 Comment | 06 Jun, 2018

Sun Pharmaceutical Industries Ltd has recently received a Corporate Social Responsibility (CSR) Award from the Federation of Gujarat Industries (FGI) for outstanding contribution in the fie...Read more

USFDA approves Mylan and Biocon’s Fulphila

Company |  News | 0 Comment | 05 Jun, 2018

Mylan N.V.  and Biocon Ltd. have announced that the U.S. Food and Drug Administration (FDA) has approved Mylan’s Fulphila (pegfilgrastim-jmbd), a biosimilar to Neu...Read more

TMH team presents Biocon’s Nimotuzumab study results at ASCO 2018

Company |  News | 0 Comment | 04 Jun, 2018

Biocon Ltd., Asia's premier biopharmaceuticals company, recently announced that a Tata Memorial Hospital (TMH), Mumbai team led by Dr Kumar Prabhash, Head, Solid Unit, Medical Oncology pres...Read more

Lupin launches oral drug Solosec in US

Company |  News | 0 Comment | 03 Jun, 2018

Pharma major Lupin has recently announced the launch of Solosec (secnidazole) 2g oral granules in the US market, having received an approval from the United States Food and Drug Administrat...Read more

Lupin appoints Nicholas Hart as head of specialty biz in US

Company |  News | 0 Comment | 01 Jun, 2018

Drug maker Lupin has appointed Nicholas Hart as President of its Specialty business in US. Hart will lead the specialty strategic business unit in the US and will be responsible for its bu...Read more

Pfizer's Xalkori receives FDA breakthrough therapy designation

Company |  News | 0 Comment | 31 May, 2018

Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for XALKORI (crizotinib) for the treatment of patients with metastati...Read more

AstraZeneca expands Global Medicines Development centre in India

Company |  News | 0 Comment | 30 May, 2018

Global science-led biopharmaceutical company AstraZeneca officially opened its new Global Medicines Development (GMD) Centre in Bengaluru, India today. This unit is one of AstraZeneca&rsquo...Read more

Sanofi Genzyme partners with MSSI

Company |  News | 0 Comment | 30 May, 2018

Sanofi Genzyme, the specialty care global business unit of Sanofi, and Multiple Sclerosis Society of India (MSSI) join hands to raise awareness and to provide better treatment solutions for...Read more

Himalaya BabyCare honours nurses across India

Company |  News | 0 Comment | 29 May, 2018

Himalaya BabyCare, India’s leading homegrown baby care brand, recognized and felicitated over 80 nurses across various government and private hospitals at Mumbai. A flagship initiativ...Read more

Strides Shasun needs shareholders' nod to change its name

Company |  News | 0 Comment | 29 May, 2018

Drug firm Strides Shasun has sought shareholders' nod to change its name to Strides Pharma Science.   This is the second time in three years when the name of the company will change....Read more